EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion

Cansu Yıldırım

Molecular Biology Reports · 2024-12 · 51 (1)

DOI: 10.1007/s11033-024-09563-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 25.04.2024. Verfasst von Cansu Yıldırım. Beteiligte Einrichtung: Atatürk Vocational School of Health Services, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey. cansu.yalcin@afsu.edu.tr. Hauptthemen laut MEDLINE: Galectins, Leukemia, Hepatitis A Virus Cellular Receptor 2, Cell Transformation, Neoplastic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 90 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leukemia is a malignancy of the bone marrow and blood originating from self-renewing cancerous immature blast cells or transformed leukocytes. Despite improvements in treatments, leukemia remains still a serious disease with poor prognosis because of disease heterogeneity, drug resistance and relapse. There is emerging evidence that differentially expression of co-signaling molecules play a critical role in tumor immune evasion. Galectin-9 (Gal-9) is one of the key proteins that leukemic cells express, secrete, and use to proliferate, self-renew, and survive. It also suppresses host immune responses controlled by T and NK cells, enabling leukemic cells to evade immune surveillance. The present review provides the molecular mechanisms of Gal-9-induced immune evasion in leukemia. Understanding the complex immune evasion machinery driven by Gal-9 expressing leukemic cells will enable the identification of novel therapeutic strategies for efficient immunotherapy in leukemic patients. Combined treatment approaches targeting T-cell immunoglobulin and mucin domain-3 (Tim-3)/Gal-9 and other immune checkpoint pathways can be considered, which may enhance the efficacy of host effector cells to attack leukemic cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GalectinsLeukemiaHepatitis A Virus Cellular Receptor 2Cell Transformation, NeoplasticHumansAnimalsImmune ToleranceSignal TransductionTumor EscapeCell ProliferationKiller Cells, Natural

Stichwörter der Autor:innen

Galectin-9Immune escapeLeukemiaTim-3

Substanzen

GalectinsLGALS9 protein, humanHepatitis A Virus Cellular Receptor 2HAVCR2 protein, human

Autor:innen und Institutionen

  • Atatürk Vocational School of Health Services, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey. cansu.yalcin@afsu.edu.tr.

Zitieren

APA

Yıldırım, C. (2024). Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion. Molecular Biology Reports, 51(1). https://doi.org/10.1007/s11033-024-09563-w

Vancouver

Yıldırım C. Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion. Molecular Biology Reports. 2024;51(1). doi:10.1007/s11033-024-09563-w

BibTeX
@article{Yldrm2024,
  author = {Yıldırım, Cansu},
  title = {Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion},
  journal = {Molecular Biology Reports},
  year = {2024},
  volume = {51},
  number = {1},
  doi = {10.1007/s11033-024-09563-w}
}
Kostenlos starten →